Table 1 Demographic and psychometric data.
From: Alterations in center-surround contrast suppression in patients with major depressive disorder
Parameter | MDD (N = 21) | HC (N = 23) | p-value |
|---|---|---|---|
ICD-10 diagnosis: F32.2/F33.2 | 12 (57%)/9 (43%) | ‒ | ‒ |
Sex: female/male | 17 (81%)/4 (19%) | 18 (78%)/5 (22%) | 0.562 (ns)# |
Age in years | 29 (21,36); 19‒61 | 32 (23,36); 21‒61 | 0.651 (ns)# |
Visual acuity as logMAR | − 0.08 (− 0.17, − 0.03); − 0.22‒0.09 | − 0.14 (− 0.19, − 0.10); − 0.29‒0.05 | 0.125 (ns)# |
Antidepressant medication yes/no | 13 (62%)/8 (38%) | ‒ | ‒ |
Days of antidepressant medication | 7 (4,11); 1‒14 | ‒ | ‒ |
Antidepressant medication: | ‒ | ‒ | |
SSRI | 1 (5%) | ‒ | ‒ |
SNRI | 2 (9%) | ‒ | ‒ |
Mirtazapine | 4 (18%) | ‒ | ‒ |
SSRI + Mirtazapine | 4 (18%) | ‒ | ‒ |
SNRI + Mirtazapine | 2 (9%) | ‒ | ‒ |
MADRS | 36+ (35, 40); 28‒45 | ‒ | ‒ |
BDI-II | 29 (25, 40); 14‒53 | 2+ (1, 6); 0‒11 | < 0.001 (*)# |
AQ | 20 (16, 22); 9‒28 | 22+ (19, 25); 16‒27 | 0.219 (ns)# |
EQ | 44 (41, 49); 29‒52 | 47+ (45, 49); 38‒59 | 0.070 (ns)# |
WURS-k | 8 (3, 13); 0‒42 | 5+ (2, 11); 0‒30 | 0.522 (ns)# |
Smoking: yes/no | 3 (14%)/18 (86%) | 4 (17%)/19 (83%) | 0.627(ns)# |
FTND | N = 3: 3 (2, 4); 2‒4 | N = 4: 2 (1, 2); 1‒3 | 0.403 (ns)# |
Coffein intake | 2 (1, 3); 0‒3 | 3 (1, 3); 0‒3 | 0.561 (ns)# |
Alcohol intake | 1 (1, 2); 0‒3 | 2 (1, 2); 1‒2 | 0.200 (ns)# |